Details der Publikation - Conformationally directed drug design

Conformationally directed drug design : peptides and nucleic acids as templates or targets : based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983 / Julius A. Vida, editor, Maxwell Gordon, editor

Medienart:	E-Book

Erscheinungsjahr:	1984
Erschienen:	Washington, DC: American Chemical Society ; 1984

Reihe:	ACS symposium series - 251

Sprache:	Englisch

Beteiligte Personen:	Vida, Julius A., 1928- [HerausgeberIn] Gordon, Maxwell, 1921- [HerausgeberIn]
Congresses:	American Chemical Society ; (186th ; Washington, D.C.) ; 1983 ; Meeting

Links:	pubs.acs.org [lizenzpflichtig]

ISBN:	978-0-8412-1079-0

Nlm:	QV 745
Themen:	ACTH Adrenocorticotropic Hormone Anti-Bacterial Agents Antibiotics Antigens Aspartic Acid Proteases Aspartic proteinases Bioactive compounds Biochemical templates Chemistry, Pharmaceutical Chemistry Techniques, Synthetic Drugs Enzyme Inhibitors Enzyme inhibitors Immunoglobulins MEDICAL / Pharmacy Microbial metabolites Nucleic Acids Nucleic acid conformation Nucleic acids Peptides Pharmaceutical chemistry Protease Inhibitors Protease inhibitors Protein Kinase Inhibitors Protein conformation Protein-tyrosine kinase Proteins Receptors, Virus SCIENCE / Life Sciences / Biochemistry Somatostatin Stereochemistry Stereoisomerism Structure-Activity Relationship T cells T-Lymphocytes Viruses

Anmerkungen:	"Based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983." Distributed in print by Oxford University Press Includes bibliographical references and index

Umfang:	1 Online-Ressource (292 pages) ; illustrations

doi:	10.1021/bk-1984-0251
Weitere IDs:	bk-1984-0251

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	1841193410

Internformat


LEADER	01000cam a22002652 4500
001	1841193410
003	DE-627
005	20240304115743.0
007	cr uuu---uuuuu
008	230404s1984 xxu\|\|\|\|\|o 00\| \|\|eng c
020			\|a 9780841210790 \|c electronic \|9 978-0-8412-1079-0
024	7		\|a 10.1021/bk-1984-0251 \|2 doi
024	8		\|a bk-1984-0251 \|q Identnummer
035			\|a (DE-627)1841193410
035			\|a (DE-599)KEP090814711
035			\|a (OCoLC)1375117799
035			\|a (ACS)bk-1984-0251
035			\|a (EBP)090814711
040			\|a DE-627 \|b eng \|c DE-627 \|e rda
041			\|a eng
044			\|c XD-US
050		0	\|a RS401
060		0	\|a QV 745
072		7	\|a SCI007000 \|a MED072000 \|2 bisacsh
245	1	0	\|a Conformationally directed drug design \|b peptides and nucleic acids as templates or targets : based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983 \|c Julius A. Vida, editor, Maxwell Gordon, editor
264		1	\|a Washington, DC \|b American Chemical Society \|c 1984
300			\|a 1 Online-Ressource (292 pages) \|b illustrations
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
490	0		\|a ACS symposium series \|v 251
500			\|a "Based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983."
500			\|a Distributed in print by Oxford University Press
500			\|a Includes bibliographical references and index
505	8	0	\|t Virus—Receptor Interactions / \|r FIELDS, BERNARD N.; GREENE, MARK I. /
505	8	0	\|t Design of Peptide Superagonists and Antagonists: Conformational and Dynamic Considerations / \|r HRUBY, VICTOR J. /
505	8	0	\|t Localization and Synthesis of Protein Antigenic Sites: Use of Free Synthetic Peptides for the Preparation of Antibodies and T-Cells of Preselected Specificities / \|r ATASSI, M. ZOUHAIR /
505	8	0	\|t Studies on New Microbial Secondary Metabolites with Potential Usefulness: Antibiotics, Enzyme Inhibitors, and Immunomodifiers / \|r UMEZAWA, HAMAO /
505	8	0	\|t Conformation of Nucleic Acids and Their Interactions with Drugs / \|r WANG, ANDREW H.-J. /
505	8	0	\|t Substrate Analog Inhibitors of Highly Specific Proteases / \|r BURTON, JAMES /
505	8	0	\|t Structure-Behavioral Activity Relationships of Peptides Derived from ACTH: Some Stereochemical Considerations / \|r VAN NISPEN, J. W.; GREVEN, H. M. /
505	8	0	\|t Design of Novel Cyclic Hexapeptide Somatostatin Analogs from a Model of the Bioactive Conformation / \|r FREIDINGER, ROGER M.; VEBER, DANIEL F. /
505	8	0	\|t Design of Kinase Inhibitors: Conformational and Mechanistic Considerations / \|r KENYON, GEORGE L.; REDDICK, REBECCA E. /
505	8	0	\|t Design and Discovery of Aspartyl Protease Inhibitors: Mechanistic and Clinical Implications / \|r RICH, DANIEL H.; SALITURO, FRANCESCO G.; HOLLADAY, MARK W.; SCHMIDT, PAUL G. /
505	8	0	\|t Design of Peptide Analogs: Theoretical Simulation of Conformation, Energetics, and Dynamics / \|r STRUTHERS, R. S.; HAGLER, A. T.; RIVIER, J. /
650		0	\|a Pharmaceutical chemistry
650		0	\|a Peptides
650		0	\|a Nucleic acids
650		0	\|a Biochemical templates
650		0	\|a Drugs \|x Structure-activity relationships
650		0	\|a Stereochemistry
650		0	\|a Viruses \|x Receptors
650		0	\|a Peptides \|x Conformation
650		0	\|a Peptides \|x Design
650		0	\|a Proteins \|x Synthesis
650		0	\|a Antigens \|x Synthesis
650		0	\|a Peptides \|x Synthesis
650		0	\|a Immunoglobulins
650		0	\|a T cells
650		0	\|a Microbial metabolites
650		0	\|a Antibiotics
650		0	\|a Enzyme inhibitors
650		0	\|a Protease inhibitors \|x Design
650		0	\|a ACTH
650		0	\|a Somatostatin \|x Design
650		0	\|a Bioactive compounds \|x Design
650		0	\|a Protein-tyrosine kinase \|x Inhibitors \|x Design
650		0	\|a Aspartic proteinases \|x Inhibitors \|x Design
650		0	\|a Peptides \|x Chemical simulation
650		2	\|a Nucleic acid conformation
650		2	\|a Protein conformation
650		2	\|a Chemistry, Pharmaceutical
650		2	\|a Receptors, Virus \|x chemistry
650		2	\|a Chemistry Techniques, Synthetic
650		2	\|a Peptides \|x chemical synthesis
650		2	\|a Peptides \|x chemistry
650		2	\|a Peptides \|x pharmacology
650		2	\|a Proteins \|x chemical synthesis
650		2	\|a Antigens \|x chemistry
650		2	\|a Immunoglobulins \|x chemistry
650		2	\|a Immunoglobulins \|x pharmacology
650		2	\|a T-Lymphocytes \|x chemistry
650		2	\|a Anti-Bacterial Agents \|x pharmacology
650		2	\|a Enzyme Inhibitors \|x pharmacology
650		2	\|a Protease Inhibitors \|x pharmacology
650		2	\|a Adrenocorticotropic Hormone \|x pharmacology
650		2	\|a Somatostatin \|x pharmacology
650		2	\|a Protein Kinase Inhibitors \|x Pharmacology
650		2	\|a Aspartic Acid Proteases \|x pharmacology
650		2	\|a Stereoisomerism
650		2	\|a Nucleic Acids \|x pharmacology
650		2	\|a Structure-Activity Relationship
650		4	\|a SCIENCE / Life Sciences / Biochemistry
650		4	\|a MEDICAL / Pharmacy
700	1		\|a Vida, Julius A. \|d 1928- \|e herausgeberin \|4 edt
700	1		\|a Gordon, Maxwell \|d 1921- \|e herausgeberin \|4 edt
710	2		\|a American Chemical Society \|b Division of Medicinal Chemistry \|e SponsorIn \|4 spn
711	2		\|a American Chemical Society \|e Meeting \|n (186th \|d 1983 \|c Washington, D.C.) \|4 oth
776	1		\|z 9780841208360 \|c alk. paper : Original
776	0	8	\|i Erscheint auch als \|z 9780841208360
776	0	8	\|i Erscheint auch als \|z 0841208360
856	4	0	\|u https://pubs.acs.org/doi/book/10.1021/bk-1984-0251 \|m X:ACS \|x Verlag \|z lizenzpflichtig
912			\|a ZDB-323-ACSY
912			\|a GBV_ILN_65
912			\|a ISIL_DE-3
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a GBV_ILN_285
912			\|a ISIL_DE-517
912			\|a GBV_ILN_2001
912			\|a ISIL_DE-21
951			\|a BO
953			\|2 045F \|a 615/.31
980			\|2 65 \|1 01 \|x 0003 \|b 4454909792 \|h ACS-EBS \|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. \|y z \|z 11-01-24
980			\|2 285 \|1 01 \|x 0517 \|b 4304059092 \|h OLR-ACSY-TEST \|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. \|y z \|z 06-04-23
980			\|2 2001 \|1 01 \|x DE-21 \|b 4446510665 \|c 00 \|f --%%-- \|d --%%-- \|e --%%-- \|j n \|y l01 \|z 03-01-24
981			\|2 65 \|1 01 \|x 0003 \|r https://pubs.acs.org/doi/book/10.1021/bk-1984-0251
981			\|2 285 \|1 01 \|x 0517 \|r https://pubs.acs.org/doi/book/10.1021/bk-1984-0251
981			\|2 2001 \|1 01 \|x DE-21 \|r https://pubs.acs.org/doi/book/10.1021/bk-1984-0251
982			\|2 2001 \|1 01 \|x DE-21 \|8 00 \|s s \|a eBook-ACS-EBA-2024
995			\|2 65 \|1 01 \|x 0003 \|a ACS-EBS
995			\|2 285 \|1 01 \|x 0517 \|a OLR-ACSY-TEST
998			\|2 2001 \|1 01 \|x DE-21 \|f 44

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände